Optimization of new dihydrofolate reductase inhibitors of mycobacterium tuberculosis (mtDHFR): molecular docking, synthesis, evaluation of enzyme inhibition and antimycobacterial activity (2018)
- Authors:
- USP affiliated authors: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; DIAS, MARCIO VINÍCIUS BERTACINE - ICB ; PARISE FILHO, ROBERTO - FCF
- Unidades: FCF; ICB
- Subjects: MYCOBACTERIUM TUBERCULOSIS; INIBIDORES DE ENZIMAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 54, suppl. 1, p. 39 res. FCF073, 2018
- Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
SOUZA, Alfredo Danilo Ferreira de et al. Optimization of new dihydrofolate reductase inhibitors of mycobacterium tuberculosis (mtDHFR): molecular docking, synthesis, evaluation of enzyme inhibition and antimycobacterial activity. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 19 abr. 2024. , 2018 -
APA
Souza, A. D. F. de, Ribeiro, J. A., Ribeiro, G. M., Trossini, G. H. G., Dias, M. V. B., & Parise Filho, R. (2018). Optimization of new dihydrofolate reductase inhibitors of mycobacterium tuberculosis (mtDHFR): molecular docking, synthesis, evaluation of enzyme inhibition and antimycobacterial activity. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Souza ADF de, Ribeiro JA, Ribeiro GM, Trossini GHG, Dias MVB, Parise Filho R. Optimization of new dihydrofolate reductase inhibitors of mycobacterium tuberculosis (mtDHFR): molecular docking, synthesis, evaluation of enzyme inhibition and antimycobacterial activity. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 39 res. FCF073.[citado 2024 abr. 19 ] -
Vancouver
Souza ADF de, Ribeiro JA, Ribeiro GM, Trossini GHG, Dias MVB, Parise Filho R. Optimization of new dihydrofolate reductase inhibitors of mycobacterium tuberculosis (mtDHFR): molecular docking, synthesis, evaluation of enzyme inhibition and antimycobacterial activity. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 39 res. FCF073.[citado 2024 abr. 19 ] - Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors
- Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis
- Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells
- Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells
- Abordagem estrutural sobre biossínteses, alvos, estratégias de desenvolvimento e resistência a antimicrobianos
- Mycobacterial OtsA structures unveil substrate preference mechanism and allosteric regulation by 2-oxoglutarate and 2-phosphoglycerate
- Enzymology of pyran ring A formation in salinomycin biosynthesis
- Structural basis of the selectivity of GenN, an Aminoglycoside N-Methyltransferase involved in gentamicin biosynthesis
- Brazilian Symposium on Medicinal Chemistry - BrazMedChem, 11
- Mechanistic insights into dideoxygenation in gentamicin biosynthesis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
